Global Ophthalmic Devices and Drugs Market Research Report 2022

Report Format: PDF   |   Report ID: 5514060   |   Published Date: August 2022   |   Pages:  115  

Choose License
Highlights
The global Ophthalmic Devices and Drugs market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Ophthalmic Devices and Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Ophthalmic Devices and Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Ophthalmic Devices and Drugs in Hospital is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Ophthalmic Devices and Drugs include Zeiss, Haag Streit, Topcon, Nidek, Essilor, Ziemer, Canon, Gulden Ophthalmics and Optovue, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Ophthalmic Devices, which accounted for % of the global market of Ophthalmic Devices and Drugs in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of  % from 2022 to 2028. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Devices and Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Devices and Drugs.
The Ophthalmic Devices and Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Ophthalmic Devices and Drugs market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Devices and Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
    Zeiss
    Haag Streit
    Topcon
    Nidek
    Essilor
    Ziemer
    Canon
    Gulden Ophthalmics
    Optovue
    Quest Medical
    Phoenix DeVentures
    EyeKon Medical
    FCI Ophthalmics
    Atrion
    Sterimedix
    OPIA
    IRIDEX
    Jardon Eye Prosthetics
    Santen Pharmaceutical
    Bausch Health
    Takeda
    Novartis
    Genentech
    Allergan
    Sun Pharmaceutical Industries
    Actavis Generics
    Regeneron Pharmaceuticals
    Pfizer
    Johnson and Johnson
    Bausch and Lomb
Product Type Insights
Global markets are presented by Ophthalmic Devices and Drugs type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Ophthalmic Devices and Drugs are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Ophthalmic Devices and Drugs segment by Type
    Ophthalmic Devices
    Ophthalmic Drugs
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Ophthalmic Devices and Drugs market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Ophthalmic Devices and Drugs market.
Ophthalmic Devices and Drugs Segment by Application
    Hospital
    Clinic
    Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ophthalmic Devices and Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Devices and Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ophthalmic Devices and Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ophthalmic Devices and Drugs industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Devices and Drugs.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ophthalmic Devices and Drugs companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Ophthalmic Devices
        1.2.3 Ophthalmic Drugs
    1.3 Market by Application
        1.3.1 Global Ophthalmic Devices and Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Ophthalmic Devices and Drugs Market Perspective (2017-2028)
    2.2 Ophthalmic Devices and Drugs Growth Trends by Region
        2.2.1 Ophthalmic Devices and Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Ophthalmic Devices and Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Ophthalmic Devices and Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Ophthalmic Devices and Drugs Market Dynamics
        2.3.1 Ophthalmic Devices and Drugs Industry Trends
        2.3.2 Ophthalmic Devices and Drugs Market Drivers
        2.3.3 Ophthalmic Devices and Drugs Market Challenges
        2.3.4 Ophthalmic Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Ophthalmic Devices and Drugs Players by Revenue
        3.1.1 Global Top Ophthalmic Devices and Drugs Players by Revenue (2017-2022)
        3.1.2 Global Ophthalmic Devices and Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Ophthalmic Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Ophthalmic Devices and Drugs Revenue
    3.4 Global Ophthalmic Devices and Drugs Market Concentration Ratio
        3.4.1 Global Ophthalmic Devices and Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Ophthalmic Devices and Drugs Revenue in 2021
    3.5 Ophthalmic Devices and Drugs Key Players Head office and Area Served
    3.6 Key Players Ophthalmic Devices and Drugs Product Solution and Service
    3.7 Date of Enter into Ophthalmic Devices and Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Ophthalmic Devices and Drugs Breakdown Data by Type
    4.1 Global Ophthalmic Devices and Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2023-2028)
5 Ophthalmic Devices and Drugs Breakdown Data by Application
    5.1 Global Ophthalmic Devices and Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Ophthalmic Devices and Drugs Market Size (2017-2028)
    6.2 North America Ophthalmic Devices and Drugs Market Size by Country (2017-2022)
    6.3 North America Ophthalmic Devices and Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Ophthalmic Devices and Drugs Market Size (2017-2028)
    7.2 Europe Ophthalmic Devices and Drugs Market Size by Country (2017-2022)
    7.3 Europe Ophthalmic Devices and Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Ophthalmic Devices and Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Ophthalmic Devices and Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Ophthalmic Devices and Drugs Market Size (2017-2028)
    9.2 Latin America Ophthalmic Devices and Drugs Market Size by Country (2017-2022)
    9.3 Latin America Ophthalmic Devices and Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Ophthalmic Devices and Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Zeiss
        11.1.1 Zeiss Company Detail
        11.1.2 Zeiss Business Overview
        11.1.3 Zeiss Ophthalmic Devices and Drugs Introduction
        11.1.4 Zeiss Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.1.5 Zeiss Recent Development
    11.2 Haag Streit
        11.2.1 Haag Streit Company Detail
        11.2.2 Haag Streit Business Overview
        11.2.3 Haag Streit Ophthalmic Devices and Drugs Introduction
        11.2.4 Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.2.5 Haag Streit Recent Development
    11.3 Topcon
        11.3.1 Topcon Company Detail
        11.3.2 Topcon Business Overview
        11.3.3 Topcon Ophthalmic Devices and Drugs Introduction
        11.3.4 Topcon Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.3.5 Topcon Recent Development
    11.4 Nidek
        11.4.1 Nidek Company Detail
        11.4.2 Nidek Business Overview
        11.4.3 Nidek Ophthalmic Devices and Drugs Introduction
        11.4.4 Nidek Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.4.5 Nidek Recent Development
    11.5 Essilor
        11.5.1 Essilor Company Detail
        11.5.2 Essilor Business Overview
        11.5.3 Essilor Ophthalmic Devices and Drugs Introduction
        11.5.4 Essilor Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.5.5 Essilor Recent Development
    11.6 Ziemer
        11.6.1 Ziemer Company Detail
        11.6.2 Ziemer Business Overview
        11.6.3 Ziemer Ophthalmic Devices and Drugs Introduction
        11.6.4 Ziemer Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.6.5 Ziemer Recent Development
    11.7 Canon
        11.7.1 Canon Company Detail
        11.7.2 Canon Business Overview
        11.7.3 Canon Ophthalmic Devices and Drugs Introduction
        11.7.4 Canon Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.7.5 Canon Recent Development
    11.8 Gulden Ophthalmics
        11.8.1 Gulden Ophthalmics Company Detail
        11.8.2 Gulden Ophthalmics Business Overview
        11.8.3 Gulden Ophthalmics Ophthalmic Devices and Drugs Introduction
        11.8.4 Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.8.5 Gulden Ophthalmics Recent Development
    11.9 Optovue
        11.9.1 Optovue Company Detail
        11.9.2 Optovue Business Overview
        11.9.3 Optovue Ophthalmic Devices and Drugs Introduction
        11.9.4 Optovue Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.9.5 Optovue Recent Development
    11.10 Quest Medical
        11.10.1 Quest Medical Company Detail
        11.10.2 Quest Medical Business Overview
        11.10.3 Quest Medical Ophthalmic Devices and Drugs Introduction
        11.10.4 Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.10.5 Quest Medical Recent Development
    11.11 Phoenix DeVentures
        11.11.1 Phoenix DeVentures Company Detail
        11.11.2 Phoenix DeVentures Business Overview
        11.11.3 Phoenix DeVentures Ophthalmic Devices and Drugs Introduction
        11.11.4 Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.11.5 Phoenix DeVentures Recent Development
    11.12 EyeKon Medical
        11.12.1 EyeKon Medical Company Detail
        11.12.2 EyeKon Medical Business Overview
        11.12.3 EyeKon Medical Ophthalmic Devices and Drugs Introduction
        11.12.4 EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.12.5 EyeKon Medical Recent Development
    11.13 FCI Ophthalmics
        11.13.1 FCI Ophthalmics Company Detail
        11.13.2 FCI Ophthalmics Business Overview
        11.13.3 FCI Ophthalmics Ophthalmic Devices and Drugs Introduction
        11.13.4 FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.13.5 FCI Ophthalmics Recent Development
    11.14 Atrion
        11.14.1 Atrion Company Detail
        11.14.2 Atrion Business Overview
        11.14.3 Atrion Ophthalmic Devices and Drugs Introduction
        11.14.4 Atrion Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.14.5 Atrion Recent Development
    11.15 Sterimedix
        11.15.1 Sterimedix Company Detail
        11.15.2 Sterimedix Business Overview
        11.15.3 Sterimedix Ophthalmic Devices and Drugs Introduction
        11.15.4 Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.15.5 Sterimedix Recent Development
    11.16 OPIA
        11.16.1 OPIA Company Detail
        11.16.2 OPIA Business Overview
        11.16.3 OPIA Ophthalmic Devices and Drugs Introduction
        11.16.4 OPIA Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.16.5 OPIA Recent Development
    11.17 IRIDEX
        11.17.1 IRIDEX Company Detail
        11.17.2 IRIDEX Business Overview
        11.17.3 IRIDEX Ophthalmic Devices and Drugs Introduction
        11.17.4 IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.17.5 IRIDEX Recent Development
    11.18 Jardon Eye Prosthetics
        11.18.1 Jardon Eye Prosthetics Company Detail
        11.18.2 Jardon Eye Prosthetics Business Overview
        11.18.3 Jardon Eye Prosthetics Ophthalmic Devices and Drugs Introduction
        11.18.4 Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.18.5 Jardon Eye Prosthetics Recent Development
    11.19 Santen Pharmaceutical
        11.19.1 Santen Pharmaceutical Company Detail
        11.19.2 Santen Pharmaceutical Business Overview
        11.19.3 Santen Pharmaceutical Ophthalmic Devices and Drugs Introduction
        11.19.4 Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.19.5 Santen Pharmaceutical Recent Development
    11.20 Bausch Health
        11.20.1 Bausch Health Company Detail
        11.20.2 Bausch Health Business Overview
        11.20.3 Bausch Health Ophthalmic Devices and Drugs Introduction
        11.20.4 Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.20.5 Bausch Health Recent Development
    11.21 Takeda
        11.21.1 Takeda Company Detail
        11.21.2 Takeda Business Overview
        11.21.3 Takeda Ophthalmic Devices and Drugs Introduction
        11.21.4 Takeda Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.21.5 Takeda Recent Development
    11.22 Novartis
        11.22.1 Novartis Company Detail
        11.22.2 Novartis Business Overview
        11.22.3 Novartis Ophthalmic Devices and Drugs Introduction
        11.22.4 Novartis Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.22.5 Novartis Recent Development
    11.23 Genentech
        11.23.1 Genentech Company Detail
        11.23.2 Genentech Business Overview
        11.23.3 Genentech Ophthalmic Devices and Drugs Introduction
        11.23.4 Genentech Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.23.5 Genentech Recent Development
    11.24 Allergan
        11.24.1 Allergan Company Detail
        11.24.2 Allergan Business Overview
        11.24.3 Allergan Ophthalmic Devices and Drugs Introduction
        11.24.4 Allergan Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.24.5 Allergan Recent Development
    11.25 Sun Pharmaceutical Industries
        11.25.1 Sun Pharmaceutical Industries Company Detail
        11.25.2 Sun Pharmaceutical Industries Business Overview
        11.25.3 Sun Pharmaceutical Industries Ophthalmic Devices and Drugs Introduction
        11.25.4 Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.25.5 Sun Pharmaceutical Industries Recent Development
    11.26 Actavis Generics
        11.26.1 Actavis Generics Company Detail
        11.26.2 Actavis Generics Business Overview
        11.26.3 Actavis Generics Ophthalmic Devices and Drugs Introduction
        11.26.4 Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.26.5 Actavis Generics Recent Development
    11.27 Regeneron Pharmaceuticals
        11.27.1 Regeneron Pharmaceuticals Company Detail
        11.27.2 Regeneron Pharmaceuticals Business Overview
        11.27.3 Regeneron Pharmaceuticals Ophthalmic Devices and Drugs Introduction
        11.27.4 Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.27.5 Regeneron Pharmaceuticals Recent Development
    11.28 Pfizer
        11.28.1 Pfizer Company Detail
        11.28.2 Pfizer Business Overview
        11.28.3 Pfizer Ophthalmic Devices and Drugs Introduction
        11.28.4 Pfizer Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.28.5 Pfizer Recent Development
    11.29 Johnson and Johnson
        11.29.1 Johnson and Johnson Company Detail
        11.29.2 Johnson and Johnson Business Overview
        11.29.3 Johnson and Johnson Ophthalmic Devices and Drugs Introduction
        11.29.4 Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.29.5 Johnson and Johnson Recent Development
    11.30 Bausch and Lomb
        11.30.1 Bausch and Lomb Company Detail
        11.30.2 Bausch and Lomb Business Overview
        11.30.3 Bausch and Lomb Ophthalmic Devices and Drugs Introduction
        11.30.4 Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2017-2022)
        11.30.5 Bausch and Lomb Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Ophthalmic Devices and Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Ophthalmic Devices Table 3. Key Players of Ophthalmic Drugs Table 4. Global Ophthalmic Devices and Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global Ophthalmic Devices and Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Ophthalmic Devices and Drugs Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Ophthalmic Devices and Drugs Market Share by Region (2017-2022) Table 8. Global Ophthalmic Devices and Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Ophthalmic Devices and Drugs Market Share by Region (2023-2028) Table 10. Ophthalmic Devices and Drugs Market Trends Table 11. Ophthalmic Devices and Drugs Market Drivers Table 12. Ophthalmic Devices and Drugs Market Challenges Table 13. Ophthalmic Devices and Drugs Market Restraints Table 14. Global Ophthalmic Devices and Drugs Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Ophthalmic Devices and Drugs Market Share by Players (2017-2022) Table 16. Global Top Ophthalmic Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Devices and Drugs as of 2021) Table 17. Ranking of Global Top Ophthalmic Devices and Drugs Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Ophthalmic Devices and Drugs Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Ophthalmic Devices and Drugs Product Solution and Service Table 21. Date of Enter into Ophthalmic Devices and Drugs Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Ophthalmic Devices and Drugs Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Ophthalmic Devices and Drugs Revenue Market Share by Type (2017-2022) Table 25. Global Ophthalmic Devices and Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Ophthalmic Devices and Drugs Revenue Market Share by Type (2023-2028) Table 27. Global Ophthalmic Devices and Drugs Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Ophthalmic Devices and Drugs Revenue Market Share by Application (2017-2022) Table 29. Global Ophthalmic Devices and Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Ophthalmic Devices and Drugs Revenue Market Share by Application (2023-2028) Table 31. North America Ophthalmic Devices and Drugs Market Size by Country (2017-2022) & (US$ Million) Table 32. North America Ophthalmic Devices and Drugs Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe Ophthalmic Devices and Drugs Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe Ophthalmic Devices and Drugs Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific Ophthalmic Devices and Drugs Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America Ophthalmic Devices and Drugs Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America Ophthalmic Devices and Drugs Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa Ophthalmic Devices and Drugs Market Size by Country (2023-2028) & (US$ Million) Table 41. Zeiss Company Detail Table 42. Zeiss Business Overview Table 43. Zeiss Ophthalmic Devices and Drugs Product Table 44. Zeiss Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 45. Zeiss Recent Development Table 46. Haag Streit Company Detail Table 47. Haag Streit Business Overview Table 48. Haag Streit Ophthalmic Devices and Drugs Product Table 49. Haag Streit Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 50. Haag Streit Recent Development Table 51. Topcon Company Detail Table 52. Topcon Business Overview Table 53. Topcon Ophthalmic Devices and Drugs Product Table 54. Topcon Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 55. Topcon Recent Development Table 56. Nidek Company Detail Table 57. Nidek Business Overview Table 58. Nidek Ophthalmic Devices and Drugs Product Table 59. Nidek Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 60. Nidek Recent Development Table 61. Essilor Company Detail Table 62. Essilor Business Overview Table 63. Essilor Ophthalmic Devices and Drugs Product Table 64. Essilor Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 65. Essilor Recent Development Table 66. Ziemer Company Detail Table 67. Ziemer Business Overview Table 68. Ziemer Ophthalmic Devices and Drugs Product Table 69. Ziemer Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 70. Ziemer Recent Development Table 71. Canon Company Detail Table 72. Canon Business Overview Table 73. Canon Ophthalmic Devices and Drugs Product Table 74. Canon Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 75. Canon Recent Development Table 76. Gulden Ophthalmics Company Detail Table 77. Gulden Ophthalmics Business Overview Table 78. Gulden Ophthalmics Ophthalmic Devices and Drugs Product Table 79. Gulden Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 80. Gulden Ophthalmics Recent Development Table 81. Optovue Company Detail Table 82. Optovue Business Overview Table 83. Optovue Ophthalmic Devices and Drugs Product Table 84. Optovue Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 85. Optovue Recent Development Table 86. Quest Medical Company Detail Table 87. Quest Medical Business Overview Table 88. Quest Medical Ophthalmic Devices and Drugs Product Table 89. Quest Medical Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 90. Quest Medical Recent Development Table 91. Phoenix DeVentures Company Detail Table 92. Phoenix DeVentures Business Overview Table 93. Phoenix DeVentures Ophthalmic Devices and DrugsProduct Table 94. Phoenix DeVentures Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 95. Phoenix DeVentures Recent Development Table 96. EyeKon Medical Company Detail Table 97. EyeKon Medical Business Overview Table 98. EyeKon Medical Ophthalmic Devices and DrugsProduct Table 99. EyeKon Medical Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 100. EyeKon Medical Recent Development Table 101. FCI Ophthalmics Company Detail Table 102. FCI Ophthalmics Business Overview Table 103. FCI Ophthalmics Ophthalmic Devices and DrugsProduct Table 104. FCI Ophthalmics Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 105. FCI Ophthalmics Recent Development Table 106. Atrion Company Detail Table 107. Atrion Business Overview Table 108. Atrion Ophthalmic Devices and DrugsProduct Table 109. Atrion Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 110. Atrion Recent Development Table 111. Sterimedix Company Detail Table 112. Sterimedix Business Overview Table 113. Sterimedix Ophthalmic Devices and DrugsProduct Table 114. Sterimedix Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 115. Sterimedix Recent Development Table 116. OPIA Company Detail Table 117. OPIA Business Overview Table 118. OPIA Ophthalmic Devices and DrugsProduct Table 119. OPIA Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 120. OPIA Recent Development Table 121. IRIDEX Company Detail Table 122. IRIDEX Business Overview Table 123. IRIDEX Ophthalmic Devices and DrugsProduct Table 124. IRIDEX Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 125. IRIDEX Recent Development Table 126. Jardon Eye Prosthetics Company Detail Table 127. Jardon Eye Prosthetics Business Overview Table 128. Jardon Eye Prosthetics Ophthalmic Devices and DrugsProduct Table 129. Jardon Eye Prosthetics Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 130. Jardon Eye Prosthetics Recent Development Table 131. Santen Pharmaceutical Company Detail Table 132. Santen Pharmaceutical Business Overview Table 133. Santen Pharmaceutical Ophthalmic Devices and DrugsProduct Table 134. Santen Pharmaceutical Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 135. Santen Pharmaceutical Recent Development Table 136. Bausch Health Company Detail Table 137. Bausch Health Business Overview Table 138. Bausch Health Ophthalmic Devices and DrugsProduct Table 139. Bausch Health Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 140. Bausch Health Recent Development Table 141. Takeda Company Detail Table 142. Takeda Business Overview Table 143. Takeda Ophthalmic Devices and DrugsProduct Table 144. Takeda Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 145. Takeda Recent Development Table 146. Novartis Company Detail Table 147. Novartis Business Overview Table 148. Novartis Ophthalmic Devices and DrugsProduct Table 149. Novartis Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 150. Novartis Recent Development Table 151. Genentech Company Detail Table 152. Genentech Business Overview Table 153. Genentech Ophthalmic Devices and DrugsProduct Table 154. Genentech Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 155. Genentech Recent Development Table 156. Allergan Company Detail Table 157. Allergan Business Overview Table 158. Allergan Ophthalmic Devices and DrugsProduct Table 159. Allergan Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 160. Allergan Recent Development Table 161. Sun Pharmaceutical Industries Company Detail Table 162. Sun Pharmaceutical Industries Business Overview Table 163. Sun Pharmaceutical Industries Ophthalmic Devices and DrugsProduct Table 164. Sun Pharmaceutical Industries Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 165. Sun Pharmaceutical Industries Recent Development Table 166. Actavis Generics Company Detail Table 167. Actavis Generics Business Overview Table 168. Actavis Generics Ophthalmic Devices and DrugsProduct Table 169. Actavis Generics Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 170. Actavis Generics Recent Development Table 171. Regeneron Pharmaceuticals Company Detail Table 172. Regeneron Pharmaceuticals Business Overview Table 173. Regeneron Pharmaceuticals Ophthalmic Devices and DrugsProduct Table 174. Regeneron Pharmaceuticals Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 175. Regeneron Pharmaceuticals Recent Development Table 176. Pfizer Company Detail Table 177. Pfizer Business Overview Table 178. Pfizer Ophthalmic Devices and DrugsProduct Table 179. Pfizer Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 180. Pfizer Recent Development Table 181. Johnson and Johnson Company Detail Table 182. Johnson and Johnson Business Overview Table 183. Johnson and Johnson Ophthalmic Devices and DrugsProduct Table 184. Johnson and Johnson Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 185. Johnson and Johnson Recent Development Table 186. Bausch and Lomb Company Detail Table 187. Bausch and Lomb Business Overview Table 188. Bausch and Lomb Ophthalmic Devices and DrugsProduct Table 189. Bausch and Lomb Revenue in Ophthalmic Devices and Drugs Business (2017-2022) & (US$ Million) Table 190. Bausch and Lomb Recent Development Table 191. Research Programs/Design for This Report Table 192. Key Data Information from Secondary Sources Table 193. Key Data Information from Primary Sources List of Figures Figure 1. Global Ophthalmic Devices and Drugs Market Share by Type: 2021 VS 2028 Figure 2. Ophthalmic Devices Features Figure 3. Ophthalmic Drugs Features Figure 4. Global Ophthalmic Devices and Drugs Market Share by Application in 2021 & 2028 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Others Case Studies Figure 8. Ophthalmic Devices and Drugs Report Years Considered Figure 9. Global Ophthalmic Devices and Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 10. Global Ophthalmic Devices and Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Ophthalmic Devices and Drugs Market Share by Region: 2021 VS 2028 Figure 12. Global Ophthalmic Devices and Drugs Market Share by Players in 2021 Figure 13. Global Top Ophthalmic Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Devices and Drugs as of 2021) Figure 14. The Top 10 and 5 Players Market Share by Ophthalmic Devices and Drugs Revenue in 2021 Figure 15. North America Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 16. North America Ophthalmic Devices and Drugs Market Share by Country (2017-2028) Figure 17. United States Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. Canada Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Europe Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Ophthalmic Devices and Drugs Market Share by Country (2017-2028) Figure 21. Germany Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. France Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. U.K. Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Italy Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Russia Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Nordic Countries Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Asia-Pacific Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Ophthalmic Devices and Drugs Market Share by Region (2017-2028) Figure 29. China Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Japan Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. South Korea Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Southeast Asia Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. India Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Australia Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Latin America Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Ophthalmic Devices and Drugs Market Share by Country (2017-2028) Figure 37. Mexico Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Brazil Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Middle East & Africa Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Ophthalmic Devices and Drugs Market Share by Country (2017-2028) Figure 41. Turkey Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Saudi Arabia Ophthalmic Devices and Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Zeiss Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 44. Haag Streit Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 45. Topcon Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 46. Nidek Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 47. Essilor Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 48. Ziemer Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 49. Canon Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 50. Gulden Ophthalmics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 51. Optovue Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 52. Quest Medical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 53. Phoenix DeVentures Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 54. EyeKon Medical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 55. FCI Ophthalmics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 56. Atrion Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 57. Sterimedix Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 58. OPIA Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 59. IRIDEX Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 60. Jardon Eye Prosthetics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 61. Santen Pharmaceutical Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 62. Bausch Health Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 63. Takeda Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 64. Novartis Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 65. Genentech Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 66. Allergan Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 67. Sun Pharmaceutical Industries Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 68. Actavis Generics Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 69. Regeneron Pharmaceuticals Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 70. Pfizer Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 71. Johnson and Johnson Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 72. Bausch and Lomb Revenue Growth Rate in Ophthalmic Devices and Drugs Business (2017-2022) Figure 73. Bottom-up and Top-down Approaches for This Report Figure 74. Data Triangulation Figure 75. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us